Furthermore, regarding recurrence-free survival, univariate and multivariate Cox regression analyses revealed that CHRNA5 is an independent prognostic marker with respect to other clinical risk factors that predict cancer recurrence in HNSCC patients (Table 1). This evidence concerns the gene CHRNA5 and cancer.